Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech Sector Weekly Rewind
The Street
Saturday, October 23, 2010 - 12:35pm
tags:
biotech, investors
Detecting More Upside Potential for EXACT Sciences
Seeking Alpha
Saturday, October 23, 2010 - 12:34pm
tags:
colorectal cancer, colorectal cancer diagnostics, EXACT Sciences
4 Rules for Trading Biotech Spec Stocks
CNBC
Saturday, October 23, 2010 - 12:31pm
tags:
biotech, investors
Celgene's Acquisition Now Looks Brilliant
yahoo/Investor's Business Daily
Saturday, October 23, 2010 - 12:30pm
tags:
Celgene, companies
Celgene Nets Abraxis Bio
Yahoo/Zacks
Saturday, October 23, 2010 - 12:29pm
tags:
companies, Celgene
FDA Rejects Arena Obesity Drug
Forbes
Saturday, October 23, 2010 - 11:18am
tags:
FDA, obesity, Arena Pharmaceuticals
Genzyme Investors Are Urged to Reject Sanofi Offer as Too Low
NY Times, NY
Saturday, October 23, 2010 - 11:17am
tags:
investors, Genzyme, Sanofi, M&A
7 Big Pharma Stocks Near 52-Week Lows
Motley Fool
Saturday, October 23, 2010 - 11:16am
tags:
JNJ, Novartis, GSK, Sanofi, Amgen, Teva Pharmaceuticals, Eli Lilly
Bristol-Myers gets drug approvals, awaits more
Yahoo/AP
Saturday, October 23, 2010 - 10:42am
tags:
Bristol-Myers Squibb, ipilimumab, Sprycel
How High Could a Sanofi Bid for Genzyme Go?
WSJ Online
Saturday, October 23, 2010 - 10:41am
tags:
M&A, Genzyme, Sanofi
Lovenox Copycat Takes Market Share From Sanofi
Motley Fool
Saturday, October 23, 2010 - 10:40am
tags:
Sanofi, Lovenox, biosimilars, blood thinners, Momenta, Sandoz
Genzyme: Company worth $89 a share
Marketwatch
Friday, October 22, 2010 - 1:14pm
tags:
Genzyme, M&A, Sanofi, guidance
Earnings Preview: Bristol-Myers
Yahoo/Zacks.com
Friday, October 22, 2010 - 1:13pm
tags:
earnings, Bristol-Myers Squibb
Two Ways To Fix The Drug Business
Forbes
Friday, October 22, 2010 - 1:11pm
tags:
FDA, healthcare reform, orphan drugs, patents, clinical trials
The Top 10 Phase III Failures of 2010
Fierce Biotech
Friday, October 22, 2010 - 11:36am
tags:
clinical trials, dimebon, Medivation, Pfizer, ocrelizumab, Roche, rheumatoid arthritis, taspoglutide, diabetes, Ipsen, semagacestat, Eli Lilly, ASA404, Antisoma, Novartis, Novelos Therapeutics, AstraZeneca, zibotentan, vicriviroc, Merck, Recentin, Vical, Sanofi
Genzyme makes case for higher Sanofi deal value
Yahoo/Reuters
Friday, October 22, 2010 - 11:25am
tags:
M&A, Sanofi, Genzyme
Genzyme Drug Should Be Given as Full Dose, EMA Says
Bloomberg
Friday, October 22, 2010 - 10:56am
tags:
Fabry's disease, EMA, Genzyme, Fabrazyme
Sanofi, Merck & Co begin vet drugs sale: sources
Reuters
Friday, October 22, 2010 - 10:54am
tags:
animal health, Merck, Merial, Sanofi
Do Birth Control Pills Cause Gallbladder Damage? Bayer Will Find Out — in Court
BNET Pharma
Friday, October 22, 2010 - 10:53am
tags:
birth control pill, Bayer, Yaz, Teva Pharmaceuticals, Beyaz
Wyeth, Suing for Patent Breach, Can't Keep Mum About Earlier Settlements
Law.com
Friday, October 22, 2010 - 10:52am
tags:
patents, settlements, Wyeth, Effexor XR

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.